Understanding the Body's Defense Against Leprosy
Molecular Analysis of Host Immune Response in Leprosy
This work helps us understand how the body's immune system fights off leprosy, a bacterial infection, to find better ways to help patients.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California Los Angeles NIH-funded |
| Lab location | 1 site (Los Angeles, United States) |
| Project ID | NIH-11080325 on NIH RePORTER |
What this research studies
Our bodies have special cells called T cells that are crucial for fighting infections like leprosy. We are learning why some people with leprosy develop strong protection, while others experience a progressive infection. By studying the immune responses directly in the affected areas of patients, we can uncover the specific ways T cells work to eliminate the infection. This includes looking at how T cells release antimicrobial proteins and activate other immune cells to fight the bacteria.
Who could benefit from this research
Good fit: This research is most relevant to patients living with leprosy, particularly those with different forms of the disease or experiencing immune reactions.
Not a fit: Individuals who do not have leprosy or similar intracellular bacterial infections would not directly benefit from this specific research.
Why it matters
Potential benefit: If successful, this work could lead to new treatments or strategies that boost the body's natural ability to fight leprosy and other similar infections.
How similar studies have performed: Previous work over many years has already uncovered important mechanisms by which immune cells fight leprosy and tuberculosis, building a strong foundation for this ongoing effort.
Where this research is happening
Los Angeles, United States
- University of California Los Angeles — Los Angeles, United States (Active)
Researchers
- Principal investigator: Modlin, Robert L — University of California Los Angeles
- Study coordinator: Modlin, Robert L
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.